Daily Mail India
Daily Mail India

Never Said Patanjali Medicine Can Cure COVID-19: CEO Acharya Balkrishna

The Ministry of Ayush had requested Patanjali to supply particulars of the drugs (File)

New Delhi:

Yoga instructor Ramdev’s Patanjali Ayurved by no means claimed it could remedy COVID-19 with its medicines, Coronil and Swasari, the agency’s Chief Executive Officer Acharya Balkrishna mentioned on Tuesday, including it simply shared the beneficial final result of medical trials on sufferers. The Centre had barred the agency from promoting the merchandise after Ramdev, in a sensational declare final week, mentioned they cured 280 sufferers inside days in trials.

“We never said the medicine (coronil) can cure or control corona, we said that we had made medicines and used them in clinical controlled trial which cured corona patients. There is no confusion in it,” Acharya Balkrishna, CEO Patanjali, was quoted as saying by information company ANI.

The Ministry of Ayush had requested Patanjali to supply particulars just like the composition of the medicines, the outcomes of its analysis, the hospitals the place the analysis was performed, whether or not the corporate had a clearance from the Institutional Ethics Committee and whether or not it had registered for the medical trials.

A licensing officer had later mentioned the corporate sought a license for an “immunity booster and a cough and fever cure” and it by no means revealed that the merchandise had been a part of medication kits. The state authorities had despatched a discover to the corporate.

“In reply to our notice, Patanjali said no Corona Kit has been packaged by them. Patanjali has printed a representative picture of coronavirus on Coronil packaging. Samples of Coronil and two other drugs have been taken for testing,” YS Rawat, Licence Officer, Uttarakhand Ayurved Department, was quoted as saying by information company ANI on Tuesday.

Ramdev had mentioned the agency had collaborated with the privately-owned National Institute of Medical Sciences or NIMS University, Jaipur for medical trials.

“We are launching COVID medicines Coronil and Swasari today. We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this, 280 patients were included and 100 per cent of those recovered. We were able to control Corona and its complications in this. After this the all-important clinical control trial was conducted,” he had mentioned.

“With the help of NIMS, Jaipur we conducted the clinical control study on 95 patients. The biggest thing which came out of this is that within three days 69 per cent patients recovered and became negative from positive (cases) and within seven days 100 per cent of them became negative,” he added.

The extremely communicable illness, which has killed lakhs throughout the globe, at present has no evidence-based remedy. Doctors, nonetheless, are utilizing a number of experimental medicine and procedures which have labored for some sufferers.

With inputs from ANI

Source hyperlink